But skepticism about AI’s impact on jobs, combined with perceptions about data centers’ disruptive impacts on communities, ...
OpenAI EU AI Act incident report confirmed by European Commission after autonomous agents colonized a German wiki for six ...
While the industry obsesses over faster chips and bigger context windows, AlixPartners consultant Kevin Madura argues the real disruption ...
David Sacks argues the viral Anthropic resignation that sparked a global AI-safety panic is not what it appears. He claims the 150-million-view ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
IntroductionIn June 2026, Zscaler ThreatLabz identified a new malware family, tracked as SloppyRAT, that is likely leveraged by a ransomware-related threat actor. ThreatLabz observed SloppyRAT being ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results